LivaNova PLC $LIVN Shares Sold by Nordea Investment Management AB

Nordea Investment Management AB reduced its position in shares of LivaNova PLC (NASDAQ:LIVN) by 12.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 92,258 shares of the company’s stock after selling 12,955 shares during the period. Nordea Investment Management AB owned about 0.17% of LivaNova worth $5,689,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Arizona State Retirement System raised its stake in LivaNova by 1.7% in the third quarter. Arizona State Retirement System now owns 16,129 shares of the company’s stock valued at $845,000 after buying an additional 274 shares in the last quarter. Bayforest Capital Ltd lifted its holdings in LivaNova by 44.8% during the 3rd quarter. Bayforest Capital Ltd now owns 918 shares of the company’s stock worth $48,000 after buying an additional 284 shares during the last quarter. UMB Bank n.a. boosted its position in shares of LivaNova by 63.0% during the 3rd quarter. UMB Bank n.a. now owns 792 shares of the company’s stock worth $41,000 after acquiring an additional 306 shares in the last quarter. California State Teachers Retirement System boosted its position in shares of LivaNova by 0.9% during the 2nd quarter. California State Teachers Retirement System now owns 50,202 shares of the company’s stock worth $2,260,000 after acquiring an additional 458 shares in the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in shares of LivaNova by 31.9% in the 3rd quarter. PNC Financial Services Group Inc. now owns 1,901 shares of the company’s stock valued at $100,000 after acquiring an additional 460 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on LIVN shares. Robert W. Baird set a $75.00 target price on LivaNova in a research report on Tuesday, December 16th. Mizuho upped their price target on LivaNova from $70.00 to $72.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. Stifel Nicolaus set a $80.00 price target on shares of LivaNova in a research note on Wednesday, February 25th. Wall Street Zen raised shares of LivaNova from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 20th. Finally, Piper Sandler restated an “overweight” rating and set a $85.00 price objective on shares of LivaNova in a research report on Thursday, February 19th. Seven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $74.78.

LivaNova Stock Up 0.6%

LIVN opened at $63.65 on Friday. LivaNova PLC has a one year low of $32.48 and a one year high of $71.92. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.16 and a current ratio of 1.36. The stock has a market capitalization of $3.48 billion, a P/E ratio of -14.27 and a beta of 0.92. The business’s 50-day simple moving average is $64.91 and its 200-day simple moving average is $60.11.

LivaNova (NASDAQ:LIVN) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.06. The firm had revenue of $360.92 million for the quarter, compared to the consensus estimate of $354.31 million. LivaNova had a positive return on equity of 16.54% and a negative net margin of 17.46%.The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.81 EPS. LivaNova has set its FY 2026 guidance at 4.150-4.250 EPS. Analysts anticipate that LivaNova PLC will post 2.85 EPS for the current year.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.